Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research
Viruses · 2026
DOI: 10.3390/v18090995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von D Madan Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and T…. Hauptthemen laut MEDLINE: Dengue Virus, Antiviral Agents, Nanotechnology, Viral Proteins. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SRM Medical College Hospital & Research Centre, Faculty of Medicine and Health Sciences, SRMIST, Kattankulathur, Tamilnadu, India.
Abstract (Originalsprache)
Dengue virus (DENV), a mosquito-borne pathogen belonging to the Flaviviridae family, continues to be a major global public health concern, causing millions of infections annually across tropical and subtropical regions. The virus encodes both structural and non-structural proteins that play critical roles in its replication, assembly, and immune evasion. Despite substantial research progress, there is still no specific antiviral drug available, and current treatment remains primarily supportive. This review highlights the significance of DENV structural proteins (C, prM/M, and E) and non-structural proteins (NS1–NS5) as potential molecular targets for antiviral interventions. Green-synthesized silver, gold, and iron oxide nanoparticles have demonstrated strong inhibitory activity against DENV by targeting key viral proteins such as the envelope (E), NS3 protease/helicase, and NS5 RNA-dependent RNA polymerase. These nanoparticles interfere with viral entry, replication, and protein synthesis while exhibiting high biocompatibility and minimal cytotoxicity. Collectively, the findings discussed in this review underscore the promise of eco-friendly nanotechnology as a sustainable and effective platform for developing next-generation antiviral therapies against dengue virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603 203, Tamilnadu, India.
- Department of Transfusion Medicine & Blood Centre, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603 203…
- Division of Medical Research, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603 203, Tamilnadu, India.
ORCID-Profile: D Madan Kumar, R Raj Bharath, Kumar Sivasubramanian, Leelavathi Prakasam
Förderung
- SRM Medical College Hospital & Research Centre, Faculty of Medicine and Health Sciences, SRMIST, Kattankulathur, Tamilnadu, India
Zitieren
APA
Kumar, D. M., Bharath, R. R., Venkataraman, P., Sivasubramanian, K., & Prakasam, L. (2026). Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research. Viruses. https://doi.org/10.3390/v18090995
Vancouver
Kumar DM, Bharath RR, Venkataraman P, Sivasubramanian K, Prakasam L. Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research. Viruses. 2026. doi:10.3390/v18090995
BibTeX
@article{Kumar2026,
author = {Kumar, D Madan and Bharath, R Raj and Venkataraman, P and Sivasubramanian, Kumar and Prakasam, Leelavathi},
title = {Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18090995}
}
EUVIMED